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Copyright © 2008 JCBN Summary We examined whether octacosanol, the main component of policosanol, attenuates
disrupted hepatic reactive oxygen species metabolism associated with acute liver injury
progression in rats intoxicated with carbon tetrachloride (CCl4). In rats intoxicated with CCl4
(1 ml/kg, i.p.), the activities of serum transaminases increased 6 h after intoxication and
further increased at 24 h. In the liver of CCl4-intoxicated rats, increases in lipid peroxide
(LPO) concentration and myeloperoxidase activity and decreases in superoxixde dismutase
activity and reduced glutathione (GSH) concentration occurred 6 h after intoxication and
these changes were enhanced with an increase in xanthine oxidase activity and a decrease in
catalase activity at 24 h. Octacosanol (10, 50 or 100 mg/kg) administered orally to CCl4-
intoxicated rats at 6 h after intoxication attenuated the increased activities of serum
transaminases and the increased hepatic myeloperoxidase and xanthine oxidase activities and
LPO concentration and the decreased hepatic superoxide dismutase and catalase activities and
GSH concentration found at 24 h after intoxication dose-dependently. Octacosanol (50 or
100 mg/kg) administered to untreated rats decreased the hepatic LPO concentration and
increased the hepatic GSH concentration. These results indicate that octacosanol attenuates
disrupted hepatic reactive oxygen species metabolism associated with acute liver injury
progression in CCl4-intoxicated rats.
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Introduction
Policosanol is a mixture of high molecular weight
aliphatic alcohols, such as octacosanol, triacosanol, and
hexacosanol, isolated and purified from sugar caneOctacosanol and Oxidative Stress in Acute Liver Injury
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(Saccharum officinarum L.) wax. Fraga et al. [ 1] have
shown that the concentration of lipid peroxide (LPO) in liver
microsomes of rats administered orally with policosanol is
less than that of rats not administered and that liver
microsomes prepared from rats treated with octacosanol is
more resistant to lipid peroxidation induced by Fe2+/ADP/
NADPH or carbon tetrachloride (CCl4)/NADPH than liver
microsomes from untreated rats. Menézden et al. [2] have
reported that low-density lipoprotein (LDL) prepared from
octacosanol-treated rats is more resistant to lipid peroxida-
tion induced by copper ion than LDL from untreated rats.
Noa et al. [3] have shown that policosanol protects against
the histological changes characteristic of CCl4-induced
acute liver injury in rats.
It is well known that CCl4 induces hepatotoxicity in
humans and experimental animals. According to the present
views of the initial developmental process of CCl4-induced
hepatotoxicity, the process is dominated by factors such as
CCl4 activation to trichloromethyl radical (·CCl3) and
trichloromethyl peroxy radical (CCl3O2·), the covalent
binding of ·CCl3 to membrane lipids and proteins, and the
hydrogen abstraction from polyunsaturated fatty acids by
the CCl3O2· and the ·CCl3 to initiate lipid peroxidation [4, 5].
It has been shown that an increase in hepatic lipid
peroxidation, which occurs via reactive oxygen species
(ROS), such as superoxide radical (O2·−) and hydroxyl
radical, contributes to not only the formation but also the
progression of CCl4-induced acute liver injury in rats [6–14].
It has also been shown that a single treatment of rats
with CCl4 causes disruption of hepatic antioxidant defense
systems associated with antioxidants such as reduced
glutathione (GSH) and antioxidant enzymes such as super-
oxide dismutase (SOD), an enzyme to scavenge O2·− to form
hydrogen peroxide (H2O2) and O2 and catalase, an enzyme to
decompose H2O2 to H2O and O2, and that the disruption of
hepatic antioxidant defense systems in rats with CCl4
contributes to liver injury progression rather than liver injury
formation [7–15]. In addition, we have shown that ROS,
such as O2·− and H2O2, derived from xanthine oxidase (XO)
contributes to the progression of acute liver injury in rats
treated with CCl4 and that ROS derived from infiltrated
neutrophils in the liver of CCl4-treated rats plays an
important role in liver injury progression through disruption
of hepatic ROS metabolism [10–12]. Octacosanol
[CH3(CH2)26CH2OH] is the major component of policosanol
and occupies 60–70% of total aliphatic alcohols present in
policosanol. We have reported that orally administered
octacosanol prevents the progression of CCl4-induced
acute liver injury in rats through improvement of hepatic
triglyceride accumulation [16]. However, it is still unclear
whether orally administered octacosanol attenuates dis-
rupted hepatic ROS metabolism associated with acute liver
injury progression in rats intoxicated CCl4.
Therefore, we examined whether octacosanol admin-
istered orally to rats intoxicated once with CCl4 attenuates
progressive liver injury and the changes in hepatic GSH and
LPO levels and the hepatic activities of SOD, catalase,
Se-glutathione peroxidase (Se-GSHpx), XO, and myeloper-
oxidase (MPO), an index of tissue neutrophil infiltration




(TMB), xanthine, bovine erythrocyte Cu,Zn-SOD, and
bovine serum albumin were obtained from Sigma Chemical
Co. (St. Louis, MO); dithiothreitol (DTT), phenylmethyl-
sulfonylfloride, yeast glutathione reductase, and milk XO
from Roche-Diagnostic Co. (Tokyo, Japan); CCl4, ethyl-
enediaminetetraacetic acid (EDTA), GSH, 2-thiobarbituric
acid, NADPH, and other reagents, of the highest grade, were
purchased from Wako Pure Chemical Industry Ltd. (Osaka,
Japan). All chemicals were used without further purification.
Animals
Male Wistar rats aged 5 weeks were purchased from
Nippon SLC Co. (Hamamatsu, Japan). The animals were
maintained under a daily controlled 12 h-light, 12 h-dark
lighting cycle at 23°C and 50% humidity with free access to
rat chow (Oriental MF, Oriental Yeast Co., Tokyo, Japan)
and water. All animals received humane care in compliance
with the guidelines of the Management of Laboratory
Animals in Fujita Health University, Japan.
Administration of CCl4 and octacosanol
CCl4 was diluted two-fold with olive oil. Fed rats (six
weeks old) received a single intraperitoneal (i.p.) injection
of CCl4 at a dose of 1 ml/kg body weight (BW), that is,
2 ml/kg BW of the 50% CCl4 solution. Rats without CCl4
intoxication received an equal volume of olive oil in the
same manner. These animals were starved with free access
to water after CCl4 intoxication, as described in our previous
reports [9–12,  16]. Octacosanol (1, 5 or 10 mg) was
suspended in 1 ml of olive oil. Each suspension of
octacosanol was orally administered to rats with and
without CCl4 intoxication at a dose of 1 ml/100 g BW at 6 h
after intoxication. The doses of octacosanol were 10, 50, and
100 mg/kg BW. Rats not administered with octacosanol
received olive oil at a dose of 1 ml/100 g BW at the same
time point.
Sample preparation
Rats were sacrificed after collecting blood from the
inferior vena cava under ether anesthesia at 6 or 24 h after
CCl4 intoxication. Immediately after sacrifice, livers wereY. Ohta et al.
J. Clin. Biochem. Nutr.
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perfused with ice-cold 0.9% NaCl through the portal vein to
remove residual blood in the tissue as much as possible and
then removed from the body. The isolated liver was washed
well in ice-cold 0.9% NaCl, clotted on a filter, weighed, and
frozen on dry ice as soon as possible. The collected blood
was kept on ice for 30 min and then separated into serum by
centrifugation at 4°C. The isolated liver and serum were kept
at −80°C until use. For the assays of hepatic LPO, GSH,
SOD, catalase, Se-GSHpx, and MPO, a part of the right
large lobe of each liver was homogenized in 9 volumes of
ice-cold 0.15 M KCl containing 1.0 mM EDTA using a
glass homogenizer with a Telfon pestle. For SOD, catalase,
Se-GSHpx, and MPO assays, the prepared homogenate was
sonicated on ice twice × 30 s using a Handy Sonic model
UR-20P (Tomy Seiko Co., Tokyo, Japan). The sonicated
homogenate was centrifuged at 12,000 × g for 20 min at
4°C. The supernatant was dialyzed against 100 volumes of
the same buffered solution at 4°C for 60 min using a
microdialysis device (MWCO = 3,500 daltons) (Bio-Tec
International Inc., Belleuve, WA). For hepatic XO assays,
another part of the right large lobe of each liver was homo-
genized in 9 volumes of an ice-cold buffered solution
(pH 7.8) containing 0.05 M potassium phosphate, 0.1 M
EDTA, 0.5 mM DTT, 0.5 mg/ml of leupeptin, and 0.2 mM
phenylmethylsulfonylfluoride using a glass homogenizer
with a Telfon pestle as described previously [10–12]. The
homogenate was dialyzed against 100 volumes of the same
buffered solution without DTT at 4°C for 60 min using the
above-described microdialysis device.
Assays of serum and hepatic components and enzymes
Serum alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) were assayed using a commercial
kit, Iatorzyme TA-LQ (Dai-Iatron Co., Tokyo, Japan). Both
activities are expressed as an international unit (IU/l).
Hepatic LPO was determined by the method of Ohkawa
et al. [ 20] using the thiobarbituric acid reaction except
that 1.0 mM EDTA was added to the reaction mixture. The
concentration of LPO is expressed as the amount of
malondialdehyde (MDA) equivalents. Hepatic GSH was
determined by the method of Sedlak and Lindsay [21] using
Ellman’s reagent and GSH as a standard. Hepatic SOD,
catalase, and Se-GSH-Px were assayed by the methods of
Oyanagui [22], Bergmeyer [23], and Hochstein, and Utley
[24], respectively. SOD activity was determined at 37°C by
the xanthine oxidase-NH2OH method using purified bovine
erythrocyte SOD (5000 units/mg solid) as a standard. SOD
activity is expressed as the amount of the erythrocyte SOD
showing activity equivalent to the determined activity.
Catalase activity was measured at 37°C by recording H2O2
decomposition at 240 nm. One unit (U) of this activity is
defined as the amount of enzyme decomposing 1 µmol H2O2
per min. Se-GSH-Px activity was determined at 37°C by
recording the decrease in absorbance at 340 nm following
the oxidation of NADPH in the presence of H2O2, GSH,
yeast GSSG-R, and NaN3 as a catalase inhibitor. One unit
(U) of this activity is defined as the amount of enzyme
oxidizing 1 µmol NADPH per min. Hepatic XO was assayed
at 30°C by the method of Hashimoto [25] using xanthine as
a substrate. XO activity was assessed by measuring the
increase in absorbance at 292 nm following the formation of
uric acid. One unit (U) of XO activity is defined as the
amount of enzyme forming 1 µmol uric acid per min.
Hepatic MPO was assayed as follows: the dialyzed
supernatant was incubated at 60°C for 2 h to increase the
recovery of MPO in liver tissues according to the method of
Schierwagen  et al. [ 18]. This heat treatment caused a
complete inactivation of catalase, which is known to
influence the assay of MPO in liver tissues. MPO activity in
the heat-treated supernatant was assessed by measuring
H2O2-dependent oxidation of TMB at 37°C according to the
method of Suzuki et al. [ 26]. This TMB oxidation was
measured spectrophotometrically at 655 nm. One unit of this
enzyme activity is expressed as the amount of enzyme
causing a change in absorbance of 1.0 per min at 655 nm.
Protein in liver tissue samples was measured by the method
of Lowry et al. [ 27] using bovine serum albumin as a
standard.
Statistical analysis
All values obtained are expressed as the mean ± SD. All
data were statistically analyzed by computerized statistical
packages (StatView). Each mean value is compared by one-
way analysis of variance and Fisher’s protected significant
difference for multicomparison as the post hoc test. The
level of significance was set at p<0.05.
Results
In rats intoxicated with CCl4 (1 ml/kg BW), serum ALT
and AST activities significantly increased 6 h after intoxica-
tion and further increased at 24 h (Fig. 1). When octacosanol
(10, 50 or 100 mg/kg BW) was administered to CCl4-
intoxicated rats at 6 h after intoxication, the increases in
serum ALT and AST activities found at 24 h after CCl4
intoxication were significantly depressed in a dose-
dependent manner (Fig. 1). The serum ALT and AST
activities in the CCl4-intoxicated group post-administered
with octacosanol (100 mg/kg BW) were significantly higher
than those in the control group but were not significantly
different from those in the CCl4-intoxicated group found at
the time point of the alcohol administration (Fig. 1). The
same does of octacosanol had no effect on serum ALT and
AST activities in CCl4-untreated rats (Fig. 1).
In CCl4-intoxicated rats, a significant increase in hepatic
LPO concentration and a significant decrease in hepaticOctacosanol and Oxidative Stress in Acute Liver Injury
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GSH concentration occurred 6 and 24 h after intoxication
and these changes were larger at 24 h than at 6 h (p<0.05)
(Fig. 2). Octacosanol administered at 6 h after CCl4
intoxication significantly attenuated the increase in hepatic
LPO concentration and the decrease in hepatic GSH concen-
tration found at 24 h after intoxication in a dose-dependent
manner (Fig. 2). The CCl4-intoxicated group post-admin-
istered with octacosanol (100 mg/kg BW) had significantly
higher hepatic LPO concentration and lower hepatic GSH
concentration than the control group (Fig. 2). However,
the hepatic LPO and GSH concentrations in the CCl4-
intoxicated group post-administered with octacosanol (100
mg/kg BW) were not significantly different from those in the
CCl4-intoxicated group found at the time point of the alcohol
administration (Fig. 2). When the same doses of octacosanol
(50 or 100 mg/kg BW) were given to CCl4-untreated rats,
both a significant decrease in LPO concentration and a
significant increase in GSH concentration were found in
the liver tissue (Fig. 2).
CCl4-intoxicated rats had significantly lower hepatic SOD
activity than control rats at 6 and 24 h after intoxication and
this decrease in activity was larger at 24 h than at 6 h
(p<0.05) (Fig. 3). The CCl4-intoxicated group had signifi-
cantly lower hepatic catalase activity than the control group
at 24 h after intoxication but showed no change in hepatic
Se-GSHpx activity at 6 and 24 h (Fig. 3). Octacosanol (10,
50 or 100 mg/kg BW) post-administered to CCl4-intoxicated
rats significantly attenuated the decrease in hepatic SOD
and catalase activities found at 24 h after intoxication in a
dose-dependent manner but had no effect on the hepatic
Se-GSHpx activity (Fig. 3). The hepatic SOD activity in the
CCl4-intoxicated group post-administered with octacosanol
(100 mg/kg BW) was significantly lower than that in the
control group but was not significantly different from that in
the CCl4-intoxicated group found at the time point of the
alcohol administration (Fig. 3A). The hepatic catalase
activity in the CCl4-intoxicated group post-administered
with octacosanol (100 mg/kg BW) was significantly lower
than that in the control group, although there was a little
difference in that activity between both groups (Fig. 3B).
Fig. 1. Effect of post-administered octacosanol on serum ALT
(A) and AST (B) activities in rats intoxicated with CCl4.
Rats with and without a single intoxication of CCl4
(1 ml/kg BW, i.p.) were orally administered with octa-
cosanol (10, 50 or 100 mg/kg BW) or olive oil (vehicle)
6 h after intoxication. Serum ALT and AST were
assayed 6 and 24 h after CCl4 intoxication as described
in Materials and Methods. Each vale is a mean ± SD
(n = 5 for CCl4-untreated rats with and without octa-
cosanol administration; n = 10 for CCl4-intoxicated rats
with and without octacosanol administration). *p<0.05
(vs control group); #p<0.05 (vs CCl4-intoxicated group).
Fig. 2. Effect of post-administered octacosanol on hepatic LPO
(A) and GSH (B) concentrations in rats intoxicated with
CCl4. Experiment condition and explanation are the
same as described in the legend for Fig. 1 except that
hepatic LPO and GSH were assayed as described in
Materials and Methods.Y. Ohta et al.
J. Clin. Biochem. Nutr.
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The same doses of octacosanol given to CCl4-untreated rats
did not affect the hepatic SOD, catalase, and Se-GSHpx
activities (Fig. 3).
CCl4-intoxicated rats had significantly higher XO activity
than control rats at 24 h after intoxication and had signifi-
cantly higher hepatic MPO activity than control rats at 6 and
24 h, although the increased hepatic MPO activity was
significantly higher at 24 h than at 6 h (p<0.05) (Fig. 4).
Octacosanol (10, 50 or 100 mg/kg BW) post-administered to
CCl4-intoxicated rats significantly attenuated the increase in
hepatic XO and MPO activities found 24 h after intoxication
in a dose-dependent manner (Fig. 4). The hepatic MPO
activity in CCl4-intoxicated group post-administered with
octacosanol (100 mg/kg BW) was significantly higher than
that in the control group but was not significantly different
from that in the CCl4-intoxicated group found at the time
point of the alcohol administration (Fig. 4B). The same
doses of octacosanol given to CCl4-untreated rats did not
affect the hepatic XO and MPO activities (Fig. 4).
Discussion
In the present study, rats intoxicated once with CCl4
(1 ml/kg BW) showed apparent liver injury at 6 h after
intoxication and progressed liver injury at 24 h, judging
from the serum levels of ALT and AST, indices of liver cell
damage, as shown in our previous reports [7, 9–12, 16].
When octacosanol (10, 50 or 100 mg/kg BW) was orally
administered to CCl4-intoxicated rats at 6 h after intoxica-
tion, the severity of progressed liver injury found at 24 after
intoxication was reduced in a dose-dependent manner. The
severity of liver injury in CCl4-intoxicated rats post-
administered with octacosanol (100 mg/kg BW) was almost
equal to that in rats intoxicated with CCl4 alone found at the
time point of the alcohol administration, as shown in our
previous report [16]. Thus, orally administered octacosanol
Fig. 3. Effect of post-administered octacosanol on hepatic SOD
(A), catalase (B), and Se-GSHpx (C) activities in rats
intoxicated with CCl4. Experiment condition and
explanation are the same as described in the legend for
Fig. 1 except that hepatic SOD, catalase, and Se-GSHpx
were assayed as described in Materials and Methods.
Fig. 4. Effect of post-administered octacosanol on hepatic XO
(A) and MPO (B) activities in rats intoxicated with CCl4.
Experiment condition and explanation are the same as
described in the legend for Fig. 1 except that hepatic XO
and MPO were assayed as described in Materials and
Methods.Octacosanol and Oxidative Stress in Acute Liver Injury
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can prevent the progression of acute liver injury in CCl4-
intoxicated rats almost completely. This finding indicates
clearly that orally administered octacosanol prevents the
progression of acute liver injury in rats intoxicated with
CCl4.
In the present study, CCl4-intoxicated rats showed an
increase in hepatic LPO concentration and a decrease in
hepatic GSH concentration at an early stage of liver injury
followed by enhanced changes in the levels of both
components at a progressed stage of the injury, as reported
previously [7–12]. Octacosanol (10, 50 or100 mg/kg BW)
administered at an early stage of CCl4-induced liver injury
attenuated the changes in hepatic LPO and GSH concentra-
tions found at a progressed stage of the injury in a dose-
dependent manner. The LPO and GSH concentrations in
CCl4-intoxicated rats given octacosanol (100 mg/kg BW)
were almost equal to those in CCl4-intoxicated rats found at
the time point of the alcohol administration. In addition,
octacosanol given to rats without CCl4 intoxication at a dose
of 50 or 100 mg/kg BW caused a significant decrease in the
hepatic LPO concentration and a significant increase in the
hepatic GSH concentration. However, it is known that
tetracosanol, hexacosanol, and octacosanol, which are the
main components of policosanol, have little activity to
scavenge 2,2'-diphenyl-1-picrylhydrazyl free radical and
no activity to inhibit copper ion-induced LDL oxidation
when they are added to each reaction medium directly [28].
We have observed that octacosanol has no inhibitory effect
on lipid peroxidation induced by a free radical generator,
2,2'-azobis(2-amidinopropane), in rat liver microsomes
when the alcohol at concentrations of 10 to 1000 µg/ml is
added to the reaction medium directly (unpublished data).
Therefore, these findings suggest that orally administered
octacosanol attenuates hepatic oxidative stress occurring
with liver injury progression in rats intoxicated once with
CCl4 through its indirect antioxidant action by increasing
tissue GSH level rather than its direct antioxidant action to
scavenge free radicals participating in lipid peroxidation.
The activation of CCl4 to ·CCl3 is caused via the cytochrom
P450 system in the liver [4,  5]. However, it is known
that policosanol has no inhibitory effect on the metabolism
of drugs via the cytochrom P450 system in the liver of
rats [3]. It is also known that when rats are intoxicated
with CCl4 (5 ml/kg BW, i.p.), the activation of CCl4 to ·CCl3
and CCl3O2·, the covalent binding of ·CCl3 to membrane
lipids and proteins, and the hydrogen abstraction from
polyunsaturated fatty acids by the CCl3O2· and the ·CCl3 to
initiate lipid peroxidation terminate within a few hours after
intoxication [29,  30]. Therefore, it seems unlikely that
octacosanol administered orally to CCl4-intoxicated rats at
6 h after intoxication affects the activation of CCl4 to ·CCl3
and CCl3O2· via the cytochrome P450 system followed by
the covalent binding of ·CCl3 to membrane lipids and lipid
peroxidation mediated by ·CCl3 and CCl3O2· in the liver.
In the present study, CCl4-intoxicated rats showed a
decrease in hepatic SOD activity at an early stage of
liver injury and had further decreased hepatic SOD activity
and decreased hepatic catalase activity at a progressed
stage of the injury, although there was no change in hepatic
Se-GSHpx activity, as shown in previous reports [7, 9–12].
Oral administration of octacosanol (10, 50 or 100 mg/kg
BW) to CCl4-intoxicated rats at an early stage of liver injury
attenuated the further decrease in hepatic SOD activity
and the decrease in hepatic catalase activity found at a
progressed stage of the injury in a dose-dependent manner
but had no effect on the hepatic Se-GSHpx activity. The
hepatic SOD activity in the CCl4-intoxicated rats given
octacosanol (100 mg/kg BW) was almost equal to that in
CCl4-intoxicated rats found at the time point of the alcohol
administration. Orally administered octacosanol (100 mg/kg
BW) prevented the decrease in hepatic catalase activity
found at a progressed stage of CCl4-induced liver injury
almost completely. The same doses of octacosanol given to
rats without CCl4 intoxication had no effect on the hepatic
SOD, catalase, and Se-GSHpx activities. These results
indicate that orally administered octacosanol can attenuate the
disruption of hepatic ROS-metabolizing system associated
with SOD and catalase following acute liver injury progres-
sion in rats intoxicated with CCl4.
In the present study, CCl4-intoxicated rats had increased
hepatic XO activity at a progressed stage of liver injury, as
shown in our previous reports [10–12]. Octacosanol (10, 50
or 100 mg/kg BW) administered orally to CCl4-intoxicated
rats at en early stage of liver injury attenuated the increase in
hepatic XO activity found at a progressed stage of the injury
in a dose-dependent manner, although the same doses of
octacosanol given to CCl4-untreated rats did not affect the
hepatic XO activity. The hepatic XO activity in the CCl4-
intoxicated rats post-administered with octacosanol (100
mg/kg BW) was still higher than that in control rats. The
hepatic activity of MPO, an index of tissue neutrophil
infiltration [17–19], in CCl4-intoxicated rats increased at
an early stage of liver injury and further increased at a
progressed stage of the injury, as reported previously [12].
Octacosanol (10, 50 or 100 mg/kg BW) administered orally
at an early stage of CCl4-induced liver injury reduced the
increase in hepatic MPO activity found at a progressed
stage of the injury in a dose-dependent manner. The hepatic
MPO activity in the CCl4-intoxicated rats post-administered
with octacosanol (100 mg/kg BW) was almost equal to
that in CCl4-treated rats found at the time point of the alcohol
administration. However, the same doses of octacosanol
given to rats without CCl4 intoxication had no effect on
the hepatic MPO activity. In addition, we have observed
that octacosanol does not inhibit XO and MPO activities in
the liver homogenate prepared from CCl4-intoxicated ratsY. Ohta et al.
J. Clin. Biochem. Nutr.
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when the alcohol is added to the reaction medium at
concentrations of 10–1000 µg/ml directly (unpublished
data). Thus, octacosanol administered orally to rats intoxi-
cated once with CCl4 can attenuate increased hepatic XO
activity and enhanced neutrophil infiltration in the liver
tissue.
It has been suggested that an increase in hepatic XO
activity in rats treated once with CCl4 is due to the conver-
sion of xanthine dehydrogenase (XD) to XO in the ischemic
or hypoxic liver [11]. Our recent report has shown in rats
treated once with CCl4 that neutrophils accumulated in the
liver tissue contribute to an increase in XO activity in the
liver tissue [12]. The conversion of XD to XO in tissues is
known to be caused by limited proteolysis and/or the
oxidation of sulfhydryl groups of the protein [31,  32].
Activated neutrophils not only produce ROS but also release
proteases from the cells [33,  34]. As described above,
octacosanol administration attenuated the enhanced hepatic
GSH depletion and neutrophil infiltration found in CCl4-
intoxicated rats and increased the hepatic GSH concentra-
tion in rats without CCl4 intoxication. Therefore, one can
think a possibility that orally administered octacosanol
reduces an increase in hepatic XO activity in CCl4-
intoxicated rats by inhibiting the conversion of XD to XO
via the GSH depletion-mediated oxidation of sulfhydryl
groups present in the protein of XD and/or via limited
proteolysis mediated by proteases released from infiltrated
neutrophils in the liver tissue.
It has been shown that when octacosanol (60 mg/kg BW)
is orally administered to rats, not only octacosanol but also
octacosanoic acid, an oxidation product of octacosanol,
appears in the liver and the hepatic amount of octacosanoic
acid is a few times higher than that of octacosanol [35].
Noa et al. [36] reported that oral administration of D-003, a
mixture of high molecular weight primary acids, such as
octacosanoic acid, purified from sugar cane wax, protected
against CCl4-induced acute liver injury in rats. In addition, it
is known that LDL prepared from rats administered with
D-003 is less susceptible to in vitro lipid peroxidation
induced by copper ion and a free radical generator, 2,2'-
azobis(2-amidinopropane), than LDL from rats without D-
003 administration [37], like the case of administered
policosanol [1, 2]. Therefore, there seems to be a possibility
that octacosanoic acid produced by oxidation of orally
administered octacosanol in the liver of rats intoxicated
once with CCl4 contributes to the attenuating effect of the
administered octacosanol on both liver injury progression
and disrupted hepatic ROS metabolism associated with the
injury progression by exerting an antioxidant action.
In conclusion, the results of the present study indicate that
orally administered octacosanol attenuates disrupted hepatic
ROS metabolism associated with acute liver injury progres-
sion in rats intoxicated with CCl4 through its antioxidant
action and its inhibitory action on neutrophil infiltration.
These results also suggest that these actions of orally
administered octacosanol are involved in the mechanism
by which the administered alcohol prevents the progression
of CCl4-induced acute liver injury.
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